Organogenesis Holdings (ORGO) Net Margin (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Net Margin of 150.85% for Q1 2026, down 12595.0% year-over-year from N/an in Q1 2025, and down 934.92% quarter-over-quarter from 18.07% in Q4 2025.
Organogenesis Holdings (ORGO) Net Margin (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Net Margin history runs 10 years deep, the most recent figure standing at 150.85% for Q1 2026.
- In Q1 2026, Net Margin fell 12595.0% year-over-year to 150.85%; the TTM figure through Mar 2026 stood at 2.54% (up 191.0% YoY), while the FY2025 annual figure was 4.55%, up 474.0% from the prior year.
- Net Margin for Q1 2026 stood at 150.85%, down from 18.07% in the prior quarter.
- The five-year high for Net Margin was 18.07% in Q4 2025, with the low at 150.85% in Q1 2026.
- The 5-year median for Net Margin is 1.45% (2023), against an average of 8.28%.
- The sharpest annual moves came in 2025 and 2026: Net Margin jumped 1343 bps in 2025, then sank 12595 bps in 2026.
- Organogenesis Holdings' Net Margin stood at 6.48% in 2022, then plunged by 78 bps to 1.45% in 2023, then soared by 220 bps to 4.64% in 2024, then surged by 290 bps to 18.07% in 2025, then plunged by 935 bps to 150.85% in 2026.
- Business Quant data shows ORGO's Net Margin at 150.85% in Q1 2026, 18.07% in Q4 2025, and 9.63% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | -227.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -227.03% |
| Mar 31, 2026 | -150.85% |
| Dec 31, 2025 | 18.07% |
| Sep 30, 2025 | 9.63% |
| Jun 30, 2025 | -12.08% |
| Mar 31, 2025 | -24.91% |
| Dec 31, 2024 | 4.64% |
| Sep 30, 2024 | 10.71% |
| Jun 30, 2024 | -13.09% |
| Mar 31, 2024 | -1.91% |
| Dec 31, 2023 | 1.45% |
| Sep 30, 2023 | 2.92% |
| Jun 30, 2023 | 4.53% |
| Mar 31, 2023 | -2.76% |
| Dec 31, 2022 | 6.48% |
| Sep 30, 2022 | 0.18% |
| Jun 30, 2022 | 7.20% |
| Mar 31, 2022 | -0.94% |
| Dec 31, 2021 | 14.88% |
| Sep 30, 2021 | 11.06% |